Gc MAF























Clinical cases presented here reinforce the hypothesis that GcMaf could become part of anticancer immunotherapeutic regimes.

Abstract Title: GC protein-derived macrophage-activating factor decreasesα-N-acetylgalactosaminidase levels in advanced cancer patients. Abstract Source: Oncoimmunology. 2013 Aug 1 ;2(8):e25769. Epub 2013 Jul 29. PMID: 24179708 Abstract Author(s): Lynda Thyer, Emma Ward, Rodney Smith, Jacopo Jv Branca,…